Chlordiazepoxide
/ Chlordiazepoxide, Chlordiazepoxide, Chlordiazepoxide /, Librax, Librelease, Libritabs, Librium, Menrium (chlordiazepoxide) is a small molecule pharmaceutical. Chlordiazepoxide was first approved as Limbitrol on 1982-01-01. It is used to treat alcohol withdrawal delirium and anxiety disorders in the USA. It is known to target thyrotropin-releasing hormone receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Chlordiazepoxide, Librium (discontinued: A-poxide, Chlordiazepoxide, Librelease, Libritabs, Librium, Lygen)
CombinationsChlordiazepoxide amitriptyline, Chlordiazepoxide clidinium, Librax (discontinued: Chlordiazepoxide amitriptyline, Chlordiazepoxide clidinium, Limbitrol, Menrium)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chlordiazepoxide
+
Estrogens
+
esterified
Chlordiazepoxide hydrochloride
+
Clidinium bromide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LIBRAX | Bausch Health Companies | N-012750 RX | 1982-01-01 | 1 products, RLD, RS |
Chlordiazepoxide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LIBRELEASE | Bausch Health Companies | N-017813 DISCN | 1983-09-12 | 1 products |
Hide discontinued
Chlordiazepoxide hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LIBRIUM | Bausch Health Companies | N-012301 DISCN | 1982-01-01 | 1 products |
| LIBRIUM | Bausch Health Companies | N-012249 DISCN | 1982-01-01 | 3 products, RLD |
Hide discontinued
Amitriptyline hydrochloride
+
Chlordiazepoxide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LIMBITROL | Chartwell Pharmaceuticals | N-016949 DISCN | 1982-01-01 | 1 products, RLD |
| LIMBITROL DS | Chartwell Pharmaceuticals | N-016949 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| chlordiazepoxide | ANDA | 2019-04-04 |
| chlordiazepoxide & amitriptyline hydrochloride | 2007-02-12 | |
| chlordiazepoxide and amitriptyline hydrochloride | ANDA | 2025-07-07 |
| chlordiazepoxide and amitriptyline hydrochloride chlordiazepoxide and amitriptyline hydrochloride | ANDA | 2025-06-11 |
| chlordiazepoxide hcl and clidinium bromide | ANDA | 2025-02-13 |
| chlordiazepoxide hydrochloride | ANDA | 2025-09-15 |
| chlordiazepoxide hydrochloride and clidinium bromide | ANDA | 2025-07-25 |
| chlordiazepoxide hydrochloride/clidinium bromide | unapproved drug other | 2019-04-01 |
| librax | New Drug Application | 2023-01-13 |
| not applicable | ANDA | 2021-12-27 |
Indications
FDA
EMA
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| J1990 | Injection, chlordiazepoxide hcl, up to 100 mg |
Clinical
Clinical Trials
8 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alcohol withdrawal delirium | D000430 | EFO_1000800 | — | — | — | 1 | 1 | 1 | 3 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Substance withdrawal syndrome | D013375 | EFO_0005800 | — | — | — | 1 | — | 2 | 3 |
| Depression | D003863 | — | F33.9 | — | 1 | 1 | — | — | 1 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | — | 1 | 1 | — | — | 1 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 1 | 1 | — | — | 1 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | — | — | 1 | — | — | 1 |
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chest pain | D002637 | — | R07.9 | — | — | — | — | 1 | 1 |
| Syndrome | D013577 | — | — | — | — | — | — | 1 | 1 |
| Hyperhidrosis | D006945 | — | — | — | — | — | — | 1 | 1 |
| Ganglion cysts | D045888 | — | M67.4 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Chlordiazepoxide |
| INN | chlordiazepoxide |
| Description | 7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine is a benzodiazepine. |
| Classification | Small molecule |
| Drug class | Benzodiazepine |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1 |
Identifiers
| PDB | — |
| CAS-ID | 58-25-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL451 |
| ChEBI ID | 3611 |
| PubChem CID | 2712 |
| DrugBank | DB00475 |
| UNII ID | 6RZ6XEZ3CR (ChemIDplus, GSRS) |
Target
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Chlordiazepoxide
+
Amitriptyline
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Chlordiazepoxide
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Chlordiazepoxide
+
Clidinium
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 6,452 documents
View more details
Safety
Black-box Warning
Black-box warning for: Chlordiazepoxide & amitriptyline hydrochloride, Chlordiazepoxide and amitriptyline hydrochloride, Chlordiazepoxide and amitriptyline hydrochloride chlordiazepoxide and amitriptyline hydrochloride, Chlordiazepoxide hcl and clidinium bromide, Chlordiazepoxide hydrochloride, Chlordiazepoxide hydrochloride and clidinium bromide, Chlordiazepoxide hydrochloride/clidinium bromide, Librax, Not applicable
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,826 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use